Australian biotech says it can regrow parts of heart

10/17/2005 | Sydney Morning Herald (Australia), The

Researchers at Melbourne's biotech company Mesoblast say they found a rare cell in bone marrow that can begin the regrowth process for heart muscles and arteries when it is injected into a patient and a way to grow the cell outside the body. Researchers say they will plan clinical trials in the next two months with expectations of an anti-heart disease drug being available for sale within three years.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ